Johnson & Johnson (JNJ)
189.05
+2.45 (1.31%)
NYSE · Last Trade: Oct 30th, 4:52 PM EDT
Detailed Quote
| Previous Close | 186.60 |
|---|---|
| Open | 187.08 |
| Bid | 187.00 |
| Ask | 189.43 |
| Day's Range | 186.91 - 189.38 |
| 52 Week Range | 140.68 - 194.48 |
| Volume | 6,972,736 |
| Market Cap | 496.95B |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | 5.200 (2.75%) |
| 1 Month Average Volume | 8,722,221 |
Chart
About Johnson & Johnson (JNJ)
Johnson & Johnson is a multinational corporation engaged in the development, manufacturing, and marketing of a wide range of healthcare products. The company operates through three primary segments: pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for its commitment to innovation in healthcare, producing a diverse array of products that include prescription medications for various diseases, sophisticated medical devices for surgical procedures, and widely recognized consumer brands for personal care and wellness. With a focus on improving health outcomes, the company aims to address the evolving needs of patients and consumers around the world. Read More
News & Press Releases
Via MarketBeat · October 30, 2025
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.
Via Benzinga · October 30, 2025
The financial markets are grappling with the reverberations of a significant day of declines, leaving investors and analysts alike pondering the immediate and long-term trajectory. This recent downturn has injected a fresh wave of uncertainty, prompting a re-evaluation of investment strategies and a heightened focus on key economic indicators. As
Via MarketMinute · October 30, 2025
The global financial markets, which had soared to unprecedented valuations through late 2024 and early 2025, experienced a sharp and unsettling correction in April 2025. This significant downturn, triggered by the sudden implementation of aggressive tariff policies, marked a dramatic shift from widespread optimism to palpable fear, wiping out trillions
Via MarketMinute · October 30, 2025
On October 29, 2025, the broader market exhibited a decidedly mixed performance, reflecting a prevailing sense of uncertainty among investors. Against this backdrop of fluctuating sentiment, the S&P 500 Healthcare Sector closed the day without any explicit, significant sector-wide news driving its performance. Instead, its movements largely mirrored the
Via MarketMinute · October 29, 2025
The global financial markets, as of October 30, 2025, are grappling with a complex interplay of factors, following a day characterized by stock futures pointing to a lower open and investor caution. This recent dip comes on the heels of major indexes hitting record highs, only to retract slightly after
Via MarketMinute · October 30, 2025
As the trading day of October 29, 2025, draws to a close, investors and analysts alike are keenly focused on the S&P 500, the bellwether index for the U.S. stock market. Representing 500 of the largest publicly traded companies, its daily movements offer a critical snapshot of investor
Via MarketMinute · October 29, 2025
As October 29, 2025, dawns, financial markets are awash with an extraordinary wave of investor confidence, a sentiment so potent it is propelling major global indices to unprecedented record highs. This pervasive bullishness, underpinned by a potent cocktail of robust corporate earnings, groundbreaking technological innovation, and supportive economic policies, has
Via MarketMinute · October 29, 2025
In the dynamic world of financial markets, two iconic figures dominate the landscape: the Bull and the Bear. These powerful symbols represent the contrasting forces that drive asset prices, investor sentiment, and economic conditions. Understanding the characteristics, historical precedents, and strategic implications of bull and bear markets is not merely
Via MarketMinute · October 29, 2025
Via FinancialNewsMedia · October 29, 2025
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women.
Via Benzinga · October 28, 2025
They are about as safe as dividends can get.
Via The Motley Fool · October 28, 2025
The lawsuit comes on the heels of President Trump linking Tylenol to autism.
Via Stocktwits · October 28, 2025
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the market. While specific daily performance metrics remain unreleased, today's trading likely saw the sector reacting to a
Via MarketMinute · October 27, 2025
As the calendar turns towards late 2025, prominent valuation metrics, the "Buffett Indicator" and the "Shiller CAPE Ratio," are flashing crimson, sending strong signals of a potentially significant stock market correction or even a crash looming in 2026. These historically reliable gauges of market health suggest that current equity valuations
Via MarketMinute · October 27, 2025
New York, NY – October 27, 2025 – A chorus of concern is growing louder across financial markets, with prominent voices like MarketWatch raising alarm bells over what they describe as an unprecedented overvaluation of the U.S. stock market. As major indices continue to notch new highs, analysts are pointing to
Via MarketMinute · October 27, 2025
The Dow Jones Industrial Average (DJIA) recently achieved a significant milestone, surging by over 200 points to close at an unprecedented all-time record high in October 2025. This remarkable ascent is a powerful testament to renewed market confidence and a confluence of positive economic indicators, sending a clear signal of
Via MarketMinute · October 27, 2025
One growth stock, one high-yield stock, and one Dividend King -- you should find something you like here as October draws to a close.
Via The Motley Fool · October 27, 2025
Want to invest like Buffett? You don't need billions of dollars -- just a long-term mindset and the discipline to stay consistent.
Via The Motley Fool · October 27, 2025
If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them.
Via The Motley Fool · October 27, 2025
October 24, 2025 – The U.S. stock market experienced an electrifying day of trading, with major indices soaring to unprecedented levels. The Dow Jones Industrial Average (DJIA) shattered previous records, closing above 47,000 for the first time, while the S&P 500 (SPX) surged past the 6,800 mark.
Via MarketMinute · October 24, 2025
Washington D.C., October 24, 2025 – As the U.S. federal government enters its 24th day of an ongoing shutdown, a critical "economic data blackout" is increasingly clouding the financial landscape. The prolonged funding lapse, which commenced on October 1st, has already led to significant delays in the release of
Via MarketMinute · October 24, 2025
FDA approves GSK's Blenrep combo for relapsed multiple myeloma, showing 51% reduced death risk and tripled progression-free survival in Phase 3 trial.
Via Benzinga · October 24, 2025
Washington D.C. – October 23, 2025 – The International Monetary Fund (IMF) has today released its Global Financial Stability Report (GFSR) for October 2025, titled "Shifting Ground beneath the Calm," delivering a stark warning that beneath the surface of seemingly tranquil global financial markets, significant vulnerabilities are festering. The report highlights
Via MarketMinute · October 23, 2025
Flash Purchasing Managers' Index (PMI) data, a critical economic bellwether, continues to command significant attention from financial markets and policymakers alike. Released typically a week or two ahead of final PMI figures and other major government economic reports, this forward-looking indicator provides an invaluable, real-time snapshot of the health and
Via MarketMinute · October 23, 2025